Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved

Current Medicinal Chemistry

Volumn 18, Issue 26, 2011, Pages 4065-4075

  Serini, S ^a   Fasano, E ^a   Piccioni, E ^a   Cittadini, A R M ^a   Calviello, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antitumor effect; Apoptosis; Breast cancer; Cell growth; Cell proliferation; Colon cancer; DHA; Diet; Differential effect; EPA; Molecular mechanisms

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONIC ACID; CELL NUCLEUS RECEPTOR; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; PROSTAGLANDIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PREVENTION; COLON CANCER; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; IN VITRO STUDY; IN VIVO STUDY; LIPID MEMBRANE; NONHUMAN; OXIDATION; PHYSICAL CHEMISTRY; PROSTAGLANDIN SYNTHESIS;

ANIMALS; ARACHIDONIC ACIDS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EPIDEMIOLOGIC STUDIES; FATTY ACIDS; FEMALE; FISH OILS; HUMANS; NEOPLASMS; PROSTAGLANDINS;

EID: 80052235755     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796957310     Document Type: Article

References (126)

1. Chapkin, R.S.; Kim, W.; Lupton, J.R.; McMurray, D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot. Essent. Fatty Acids, 2009, 81(2-3), 187-191.
2. von Schacky, C.; Harris, W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res., 2007, 73(2), 310-315. (Pubitemid 44937689)
3. Rose, D.P.; Connolly, J.M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther., 1999, 83(3), 217-244. (Pubitemid 29430123)
4. Karmali, R.A.; Marsh, J.; Fuchs, C. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J. Natl. Cancer Inst., 1984, 73(2), 457-461. (Pubitemid 14055227)
5. Karmali, R.A.; Reichel, P.; Cohen, L.A.; Terano, T.; Hirai, A.; Tamura, Y.; Yoshida, S. Effect of omega-3 fatty acids on growth of the DU-145 human prostatic tumor in nude mice. Anticancer Res., 1987, 7(6), 1173-1179.
6. Takata, T.; Minoura, T.; Takada, H.; Sakaguchi, M.; Yamamura, M.; Hioki, K.; Yamamoto, M. Specific inhibitory effect of dietary eicosapentaenoic acid on N-nitroso-N-methylurea-induced mammary carcinogenesis in female Sprague-Dawley rats. Carcinogenesis, 1990, 11(11), 2015-2019. (Pubitemid 20375949)
7. Reddy, B.S.; Burill, C.; Rigotty, J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res., 1991, 51(2), 487-491.
8. Ramesh, G.; Das, U.N. Effect of dietary fat on diethylnitrosamine induced hepatocarcinogenesis in Wistar rats. Cancer Lett., 1995, 95(1-2), 237-245.
9. Ip, C. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am. J. Clin. Nutr., 1997, 66(6 Suppl.), 1523S-1529S. (Pubitemid 27518219)
10. Dommels, Y.E.; Heemskerk, S.; van den Berg, H.; Alink, G.M.; van Bladeren, P.J.; van Ommen, B. Effects of high fat fish oil and high fat corn oil diets on initiation of AOM-induced colonic aberrant crypt foci in male F344 rats. Food Chem. Toxicol., 2003, 41(12), 1739-1747. (Pubitemid 37249341)
11. Manna, S.; Chakraborty, T.; Ghosh, B.; Chatterjee, M.; Panda, A.; Srivastava, S.; Rana, A.; Chatterjee, M. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz(alpha)anthracene-induced mammary carcinogenesis in rats. Prostaglandins Leukot. Essent. Fatty Acids, 2008, 79(1-2), 5-14.
12. Chatterjee, M.; Janarthan, M.; Manivannan, R.; Rana, A.; Chatterjee, M. Combinatorial effect of fish oil (Maxepa) and 1alpha,25-dihydroxyvitamin D(3) in the chemoprevention of DMBA-induced mammary carcinogenesis in rats. Chem. Biol. Interact., 2010, 188(1), 102-110.
13. Noguchi, M.; Minami, M.; Yagasaki, R.; Kinoshita, K.; Earashi, M.; Kitagawa, H.; Taniya, T.; Miyazaki, I. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br. J. Cancer, 1997, 75(3), 348-353. (Pubitemid 27051048)
14. Kinoshita, K.; Noguchi, M.; Earashi, M.; Tanaka, M.; Sasaki, T. Inhibitory effects of purified eicosapentaenoic acid and docosahexaenoic acid on growth and metastasis of murine transplantable mammary tumor. In Vivo, 1994, 8(3), 371-374. (Pubitemid 24269712)
15. Calviello, G.; Palozza, P.; Piccioni, E.; Maggiano, N.; Frattucci, A.; Franceschelli, P.; Bartoli, G.M. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int. J. Cancer, 1998, 75(5), 699-705. (Pubitemid 28145816)
16. Toriyama-Baba, H.; Iigo, M.; Asamoto, M.; Iwahori, Y.; Park, C.B.; Han, B.S.; Takasuka, N.; Kakizoe, T.; Ishikawa, C.; Yazawa, K.; Araki, E.; Tsuda, H. Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. Jpn. J. Cancer Res., 2001, 92(11), 1175-1183. (Pubitemid 33133486)
17. Yuri, T.; Danbara, N.; Tsujita-Kyutoku, M.; Fukunaga, K.; Takada, H.; Inoue, Y.; Hada, T.; Tsubura, A. Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr. Cancer, 2003, 45(2), 211-217. (Pubitemid 37022795)
18. Petrik, M.B.; McEntee, M.F.; Johnson, B.T.; Obukowicz, M.G.; Whelan, J. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J. Nutr., 2000, 130(10), 2434-2443.
19. Calviello, G.; Palozza, P.; Franceschelli, P.; Frattucci, A.; Piccioni, E.; Tessitore, L.; Bartoli, G.M. Eicosapentaenoic acid inhibits the growth of liver preneoplastic lesions and alters membrane phospholipid composition and peroxisomal beta-oxidation. Nutr. Cancer, 1999, 34(2), 206-212. (Pubitemid 29511119)
20. Takahashi, M.; Totsuka, Y.; Masuda, M.; Fukuda, K.; Oguri, A.; Yazawa, K.; Sugimura, T.; Wakabayashi, K. Reduction in formation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA). Carcinogenesis, 1997, 18(10), 1937-1941. (Pubitemid 28132378)
21. Colas, S.; Mahéo, K.; Denis, F.; Goupille, C.; Hoinard, C.; Champeroux, P.; Tranquart, F.; Bougnoux, P. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin. Cancer Res., 2006, 12(19), 5879-5886. (Pubitemid 44629621)
22. Palakurthi, S.S.; Flückiger, R.; Aktas, H.; Changolkar, A.K.; Shahsafaei, A.; Harneit, S.; Kilic, E.; Halperin, J.A. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res., 2000, 60(11), 2919-2925. (Pubitemid 30395816)
23. Calviello, G.; Serini, S.; Palozza, P. n-3 polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer. Current Signal Transduction Therapy, 2006; 1, 255-271.
24. Serini, S.; Piccioni, E.; and Calviello, G. ω-3 PUFAs and colon cancer: experimental studies and human interventional trials. In: Dietary omega-3 polyunsaturated fatty acids and cancer (Series: Diet and Cancer). Editors: G.Calviello and S. Serini, Springer publisher, 2010, pp. 67-89.
25. Edwards, I.J; Berquin, I.M.; Chen, Y.Q.; and O'Flaherty, JT. w-3 PUFAs, Breast and Prostate cancer:experimental studies. In: Dietary omega-3 polyunsaturated fatty acids and cancer (Series: Diet and Cancer). Editors: G.Calviello and S. Serini, Springer publisher, 2010, pp.167-188.
26. Blanckaert, V.; Ulmann, L.; Mimouni, V.; Antol, J.; Brancquart, L.; Chénais, B. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int. J. Oncol., 2010, 36(3):737-742.
27. Calviello, G.; Palozza, P.; Di Nicuolo, F.; Maggiano, N.; Bartoli, G.M. n-3 PUFA dietary supplementation inhibits proliferation and store-operated calcium influx in thymoma cells growing in Balb/c mice. J. Lipid Res., 2000, 41(2), 182-189.
28. Calviello, G.; Di Nicuolo, F.; Gragnoli, S.; Piccioni, E.; Serini, S.; Maggiano, N.; Tringali, G.; Navarra, P.; Ranelletti, F.O.; Palozza, P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis, 2004, 25(12), 2303-2310. (Pubitemid 39625169)
29. Calviello, G.; Resci, F.; Serini, S.; Piccioni, E.; Toesca, A.; Boninsegna, A.; Monego, G.; Ranelletti, F.O.; Palozza, P. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis, 2007, 28(6), 1202-1209. (Pubitemid 47062678)
30. Calviello, G.; Serini, S.; Piccioni, E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr. Med. Chem., 2007, 14(29), 3059-3069. (Pubitemid 350226957)
31. Serini, S.; Piccioni, E.; Merendino, N.; Calviello, G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis, 2009, 14(2), 135-152.
32. Serini, S.; Trombino, S.; Oliva, F.; Piccioni, E.; Monego, G.; Resci, F.; Boninsegna, A.; Picci, N.; Ranelletti, F.O.; Calviello, G. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 downregulating p-ERK1/2 and p-p38 expression. Apoptosis, 2008, 13(9), 1172-1183.
33. Anderson, B.M.; Ma, D.W. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis., 2009, 8, 33.
34. Brouwer, I.A. Omega-3 PUFA: good or bad for prostate cancer? Prostaglandins Leukot. Essent. Fatty Acids, 2008, 79(3-5), 97-99.
35. Chavarro, J.E.; Stampfer, M.J.; Li, H.; Campos, H.; Kurth, T.; Ma, J.A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 2007, 16(7), 1364-1370. (Pubitemid 47076865)
36. Ritch, C.R.; Wan, R.L.; Stephens, L.B.; Taxy, J.B.; Huo, D.; Gong, E.M.; Zagaja, G.P.; Brendler, C.B. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J. Urol., 2007, 177(1), 97-101. (Pubitemid 44879447)
37. Koralek, D.O.; Peters, U.; Andriole, G.; Reding, D.; Kirsh, V.; Subar, A.; Schatzkin, A.; Hayes, R.; Leitzmann, M.F. A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States). Cancer Causes Control, 2006, 17(6), 783-791.
38. Leitzmann, M.F.; Stampfer, M.J.; Michaud, D.S.; Augustsson, K.; Colditz, G.C.; Willett, W.C.; Giovannucci, E.L. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am. J. Clin. Nutr., 2004, 80(1), 204-216.
39. Schmitz, G.; Ecker, J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res., 2008, 47(2), 147-155.
40. Greenhough, A.; Smartt, H.J.; Moore, A.E.; Roberts, H.R.; Williams, A.C.; Paraskeva, C.; Kaidi, A. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 2009, 30(3), 377-386.
41. Ghosh, M.; Loper, R.; Ghomashchi, F.; Tucker, D.E.; Bonventre, J.V.; Gelb, M.H.; Leslie, C.C. Function, activity, and membrane targeting of cytosolic phospholipase A(2)zeta in mouse lung fibroblasts. J. Biol. Chem., 2007, 282(16), 11676-11686. (Pubitemid 47100705)
42. Kramer, R.M.; Sharp, J.D. Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett., 1997, 410(1), 49-53. (Pubitemid 27283382)
43. Shikano, M.; Masuzawa, Y.; Yazawa, K.; Takayama, K.; Kudo, I.; Inoue, K. Complete discrimination of docosahexaenoate from arachidonate by 85 kDa cytosolic phospholipase A2 during the hydrolysis of diacyl-and alkenylacylglycerophosphoethanolamine. Biochim. Biophys. Acta, 1994, 1212(2), 211-216. (Pubitemid 24181661)
44. Tanabe, T.; and Tohnai, N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat., 2002, 68-69, 95-114. (Pubitemid 35247390)
45. Vecchio, A.J.; Simmons, D.M.; Malkowski, M.G. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J. Biol. Chem., 2010, 285(29), 22152-22163.
46. Clària, J. Cyclooxygenase-2 biology. Curr. Pharm. Des., 2003, 9(27), 2177-2190. (Pubitemid 37139092)
47. Howe, L.R. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res., 2007, 9(4), 210.
48. Castellone, M.D.; Teramoto, H.; Gutkind, J.S. Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection. Cancer Res., 2006, 66(23), 11085-11088. (Pubitemid 46009929)
49. Dhawan, D.; Jeffreys, A.B.; Zheng, R.; Stewart, J.C.; Knapp, D.W. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Mol. Cancer Ther., 2008, 7(4), 897-904. (Pubitemid 351551043)
50. Rundhaug, J.E.; Fischer, S.M. Cyclo-oxygenase-2 plays a critical role in UVinduced skin carcinogenesis. Photochem. Photobiol., 2008, 84(2), 322-329. (Pubitemid 351424030)
51. Colby, J.K.; Klein, R.D.; McArthur, M.J.; Conti, C.J.; Kiguchi, K.; Kawamoto, T.; Riggs, P.K.; Pavone, A.I.; Sawicki, J.; Fischer, S.M. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Neoplasia, 2008, 10(8), 782-796.
52. Jiménez, P.; Piazuelo, E.; Cebrian, C.; Ortego, J.; Strunk, M.; García-Gonzalez, M.A.; Santander, S.; Alcedo, J.; Lanas, A. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. Aliment. Pharmacol. Ther., 2010, 31(3), 440-451.
53. Oshima, H.; Oguma, K.; Du, Y.C.; Oshima, M. Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models. Cancer Sci., 2009, 100(10), 1779-1785.
54. Laneuville, O.; Breuer, D.K.; Xu, N.; Huang, Z.H.; Gage, D.A.; Watson, J.T.; Lagarde, M.; DeWitt, D.L.; Smith, W.L. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. J. Biol. Chem., 1995, 270(33), 19330-19336.
55. Wada, M.; DeLong, C.J.; Hong, Y.H.; Rieke, C.J.; Song, I.; Sidhu, R.S.; Yuan, C.; Warnock, M.; Schmaier, A.H.; Yokoyama, C.; Smyth, E.M.; Wilson, S.J.; FitzGerald, G.A.; Garavito, R.M.; Sui de, X.; Regan, J.W.; Smith, W.L. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem., 2007, 282(31), 22254-22266. (Pubitemid 47267340)
56. Yuan, C.; Sidhu, R.S.; Kuklev, D.V.; Kado, Y.; Wada, M.; Song, I.; Smith, W.L. Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J. Biol. Chem., 2009, 284(15), 10046-10055.
57. Yuan, C.; Rieke, C.J.; Rimon, G.; Wingerd, B.A.; and Smith, W.L. Partnering between monomers of cyclooxygenase-2 homodimers. Proc. Natl. Acad. Sci. U.S.A., 2006, 103(16), 6142-6147.
58. Malkowski, M.G.; Ginell, S.L.; Smith, W.L.; and Garavito, R.M. The productive conformation of arachidonic acid bound to prostaglandin synthase. Science, 2000, 289(5486), 1933-1937.
59. Liu, W.; Cao, D.; Oh, S.F.; Serhan, C.N.; and Kulmacz, R.J. Divergent cyclooxygenase responses to fatty acid structure and peroxide level in fish and mammalian prostaglandin H synthases. FASEB J., 2006, 20(8), 1097-1108. (Pubitemid 44943906)
60. Funahashi, H.; Satake, M.; Hasan, S.; Sawai, H.; Newman, R.A.; Reber, H.A.; Hines, O.J.; Eibl, G. Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas, 2008, 36(4), 353-362. (Pubitemid 351591577)
61. Denkins, Y.; Kempf, D.; Ferniz, M.; Nileshwar, S.; Marchetti, D. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J. Lipid Res., 2005, 46(6), 1278-1284. (Pubitemid 43109842)
62. Chapkin, R.S.; Davidson, L.D.; Davidson, L.A. Phospholipid molecular species composition of mouse liver nuclei. Influence of dietary n-3 fatty acid ethyl esters. Biochem. J., 1992, 287(Pt 1), 237-240.
63. Lim, K.; Han, C.; Dai, Y.; Shen, M.; Wu, T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking betacatenin and cyclooxygenase-2. Mol. Cancer Ther., 2009, 8(11), 3046-3055.
64. Spencer, L.; Mann, C.; Metcalfe, M.; Webb, M.; Pollard, C.; Spencer, D.; Berry, D.; Steward, W.; Dennison, A. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur. J. Cancer, 2009, 45(12), 2077-2086.
65. Wassall, S.R.; Stillwell, W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem. Phys. Lipids, 2008, 153(1), 57-63.
66. Chapkin, R.S.; McMurray, D.N.; Davidson, L.A.; Patil, B.S.; Fan, Y.Y.; Lupton, J.R. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br. J. Nutr., 2008, 100(6), 1152-1157.
67. Stillwell, W.; Wassall, S.R. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem. Phys. Lipids, 2003, 126(1), 1-27. (Pubitemid 37297962)
68. Wassall, S.R.; Stillwell, W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim. Biophys. Acta, 2009, 1788(1), 24-32.
69. Holte, L.L.; Peter, S.A.; Sinnwell, T.M.; Gawrisch, K. 2H nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain. Biophys. J., 1995, 68(6), 2396-2403.
70. Huster, D.; Jin, A.J.; Arnold, K.; Gawrisch, K. Water permeability of polyunsaturated lipid membranes measured by 17O NMR. Biophys. J., 1997, 73(2), 855-864. (Pubitemid 27337620)
71. Ehringer, W.; Belcher, D.; Wassall, S.R.; Stillwell, W. A comparison of the effects of linolenic (18:3 omega 3) and docosahexaenoic (22:6 omega 3) acids on phospholipid bilayers. Chem. Phys. Lipids, 1990, 54(2), 79-88. (Pubitemid 20169121)
72. Pöschl, J.M.; Paul, K.; Leichsenring, M.; Han, S.R.; Pfisterer, M.; Bremer, H.J.; Linderkamp, O. Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in weanling guinea pigs. Lipids, 1999, 34(5), 467-473. (Pubitemid 29262591)
73. Olefsky, J.M. Nuclear receptor minireview series. J. Biol. Chem., 2001, 276(40), 36863-36864. (Pubitemid 37384092)
74. Xu, H.E.; Lambert, M.H.; Montana, V.G.; Parks, D.J.; Blanchard, S.G.; Brown, P.J.; Sternbach, D.D.; Lehmann, J.M.; Wisely, G.B.; Willson, T.M.; Kliewer, S.A.; Milburn, M.V. Molecular recognition of fatty acids by peroxisome proliferator activated receptors. Mol. Cell, 1999, 3(3), 397-403. (Pubitemid 29290680)
75. Thoennes, S.R.; Tate, P.L.; Price, T.M.; Kilgore, M.W. Differential transcriptional activation of peroxisome proliferator-activated receptor α by omega-3 and omega-6 fatty acids in MCF-7 cells. Mol. Cell. Endocrinol., 2000, 160(1-2), 67-73. (Pubitemid 30129053)
76. Sheu, S.H.; Kaya, T.; Waxman, D.J.; Vajda, S. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Biochemistry, 2005, 44(4), 1193-1209. (Pubitemid 40208999)
77. Kersten, S.; Desvergne, B.; Wahli, W. Roles of PPARs in health and disease. Nature, 2000, 405(6785), 421-424. (Pubitemid 30367411)
78. Elstner, E.; Müller, C.; Koshizuka, K.; Williamson, E.A.; Park, D.; Asou, H.; Shintaku, P.; Said, J.W.; Heber, D.; Koeffler, H.P. Ligands for peroxisome proliferator-activated receptor α and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. U. S. A., 1998, 95(15), 8806-8811.
79. Sun, H.; Berquin, I.M.; Owens, R.T.; O'Flaherty, J.T.; Edwards, I.J. Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res., 2008, 68(8), 2912-2919. (Pubitemid 351556291)
80. Fan, Y.Y.; Spencer, T.E.; Wang, N.; Moyer, M.P.; Chapkin, R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis, 2003, 24(9), 1541-1548. (Pubitemid 37160845)
81. Lane, J.; Mansel, R.E.; Jiang, W.G. Expression of human delta-6-desaturase is associated with aggressiveness of human breast cancer. Int. J. Mol. Med., 2003, 12(2), 253-257.
82. Morton, R.E.; Hartz, J.W.; Reitz, R.C.; Waite, B.M.; Morris, H.. The acyl-CoA desaturases of microsomes from rat liver and the Morris 7777 hepatoma. Biochim. Biophys. Acta, 1979, 573(2), 321-331. (Pubitemid 9175712)
83. Galeotti, T.; Borrello, S.; Masoti, L. Oxy radical sources, scavenger systems and membrane damage in cancer cells. In: Oxygen radicals: systemic events and disease processes. Das, D.K.; Essman, R., eds. Basel; S. Karger, 1990, pp. 129-148.
84. Bartoli, G.M.; Galeotti, T. Growth-related lipid peroxidation in tumor microsomal membranes and mitochondria. Biochim. Biophys. Acta, 1979, 574(3), 537-541. (Pubitemid 10226479)
85. Cheeseman, K.H.; Burton, G.W.; Ingold, K.U.; Slater, T.F. Lipid peroxidation and lipid antioxidants in normal and tumor cells. Toxicol. Pathol., 1984, 12(3), 235-239. (Pubitemid 15175920)
86. Das, U.N.; Huang, Y.S.; Begin, M.E.; Ells, G.; Horrobin, D.F. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Radic. Biol. Med., 1987, 3(1), 9-14.
87. Siddiqui, R.A.; Harvey, K.; Stillwell, W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem. Phys. Lipids, 2008, 153(1), 47-56.
88. Gleissman, H.; Yang, R.; Martinod, K.; Lindskog, M.; Serhan, C.N.; Johnsen, J.I.; Kogner, P. Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J., 2010, 24(3), 906-915.
89. Serhan, C.N.; Chiang, N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol., 2008, 153(Suppl 1), S200-S215. (Pubitemid 351340979)
90. Lim, K.; Han, C.; Xu, L.; Isse, K.; Demetris, A.J.; Wu, T. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res., 2008, 68(2), 553-560. (Pubitemid 351380084)
91. Noguchi, M.; Earashi, M.; Minami, M.; Kinoshita, K.; Miyazaki, I. Effects of eicosapentaenoic and docosahexaenoic acid on cell growth and prostaglandin E and leukotriene B production by a human breast cancer cell line (MDAMB-231). Oncology, 1995, 52(6), 458-464.
92. Rose, D.P.; Connolly, J.M.; Coleman, M. Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin. Cancer Res., 1996, 2(10), 1751-1756. (Pubitemid 26356361)
93. Chamras, H.; Ardashian, A.; Heber, D.; Glaspy, J.A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J. Nutr. Biochem., 2002, 13(12), 711-716. (Pubitemid 35463199)
94. Wu, M.; Harvey, K.A.; Ruzmetov, N.; Welch, Z.R.; Sech, L.; Jackson, K.; Stillwell, W.; Zaloga, G.P.; Siddiqui, R.A. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int. J. Cancer, 2005, 117(3), 340-348. (Pubitemid 41429556)
95. Schley, P.D.; Jijon, H.B.; Robinson, L.E.; Field, C.J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat., 2005, 92(2), 187-195. (Pubitemid 40933584)
96. Barascu, A.; Besson, P.; Le Floch, O.; Bougnoux, P.; Jourdan, M.L. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int. J. Biochem. Cell. Biol., 2006, 38(2):196-208. (Pubitemid 41619449)
97. Iigo, M.; Nakagawa, T.; Ishikawa, C.; Iwahori, Y.; Asamoto, M.; Yazawa, K.; Araki, E.; Tsuda, H. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br. J. Cancer, 1997, 75(5), 650-655. (Pubitemid 27091076)
98. Habermann, N.; Christian, B.; Luckas, B.; Pool-Zobel, B.L.; Lund, E.K.; Glei, M. Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. Biofactors, 2009, 35(5), 460-467.
99. Kang, K.S.; Wang, P.; Yamabe, N.; Fukui, M.; Jay, T.; Zhu, B.T. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One, 2010, 5(4), e10296.
100. Chajès, V.; Sattler, W.; Stranzl, A.; Kostner, G.M. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res. Treat., 1995, 34(3), 199-212.
101. Mali, M.; Andtfolk, H.; Miettinen, H.M.; Jalkanen, M. Suppression of tumor cell growth by syndecan-1 ectodomain. J. Biol. Chem., 1994, 269(45), 27795-27798. (Pubitemid 24354496)
102. Dhodapkar, M.V.; Abe, E.; Theus, A.; Lacy, M.; Langford, J.K.; Barlogie, B.; Sanderson, R.D. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. Blood, 1998, 91(8), 2679-2688. (Pubitemid 28227516)
103. Rose, D.P.; Connolly, J.M.; Rayburn, J.; Coleman, M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst., 1995, 87(8), 587-592.
104. Laboratory Rodent Diet. www.labdiet.com/pdf/5001.pdf
105. Minami, M.; Noguchi, M. Effects of low-dose eicosapentaenoic acid, docosahexaenoic acid and dietary fat on the incidence, growth and cell kinetics of mammary carcinomas in rats. Oncology, 1996, 53(5), 398-405. (Pubitemid 26283783)
106. Bougnoux, P.; Chajès, V.; Germain, E.; Hubert, B.; Lhuillery, C.; Le Floch, O.; Body, G.; Calais, G. Cytotoxic drug efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Lipids, 1999, 34(Suppl.), S109. (Pubitemid 29323155)
107. Kato, T.; Kolenic, N.; Pardini, R.S. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr. Cancer, 2007, 58(2), 178-187. (Pubitemid 47328769)
108. Kato, T.; Hancock, R.L.; Mohammadpour, H.; McGregor, B.; Manalo, P.; Khaiboullina, S.; Hall, M.R.; Pardini, L.; Pardini, R.S. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett., 2002, 187(1-2), 169-177. (Pubitemid 35279346)
109. Calviello, G.; Di Nicuolo, F.; Serini, S.; Piccioni, E.; Boninsegna, A.; Maggiano, N.; Ranelletti, F.O.; Palozza, P. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother. Pharmacol., 2005, 55(1), 12-20. (Pubitemid 40064491)
110. Hossain, Z.; Hosokawa, M.; Takahashi, K. Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid. Nutr. Cancer, 2009, 61(1), 123-130.
111. Calviello, G.; and Serini, S. ω-3 PUFAs, why are we speaking of them? In: Dietary omega-3 polyunsaturated fatty acids and cancer (Series: Diet and Cancer). Editors: G.Calviello and S. Serini, Springer publisher, 2010, pp. ixxxi.
112. Serini, S.; Donato, V.; Piccioni, E.; Trombino, S.; Monego, G.; Toesca, A.; Innocenti, I.; Missori, M.; De Spirito, M.; Celleno, L.; Fasano, E.; Ranelletti, F.O.; Calviello, G. Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. J. Nutr. Biochem., 2010, [Epub ahead of print].
113. Erb, P.; Ji, J.; Kump, E.; Mielgo, A.; Wernli, M. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv. Exp. Med. Biol., 2008, 624, 283-295.
114. Fischer, S.M.; Pavone, A.; Mikulec, C.; Langenbach, R.; Rundhaug, J.E. Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol. Carcinog., 2007, 46(5), 363-371. (Pubitemid 46744456)
115. Zhang, J.; Bowden, G.T. UVB irradiation regulates Cox-2 mRNA stability through AMPK and HuR in human keratinocytes. Mol. Carcinog., 2008, 47(12), 974-983.
116. Merendino, N.; Loppi, B.; D'Aquino, M.; Molinari, R.; Pessina, G.; Romano, C.; Velotti, F. Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr. Cancer, 2005, 52(2), 225-233. (Pubitemid 41579764)
117. Merendino, N.; Molinari, R.; Loppi, B.; Pessina, G.; D' Aquino, M.; Tomassi, G.; Velottia, F. Induction of apoptosis in human pancreatic cancer cells by docosahexaenoic acid. Ann. N. Y. Acad. Sci., 2003, 1010, 361-364. (Pubitemid 38265008)
118. Hu, Y.; Sun, H.; Owens, R.T.; Gu, Z.; Wu, J.; Chen, Y.Q.; O'Flaherty, J.T.; Edwards, I.J. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Neoplasia, 2010, 12(10), 826-836.
119. Nakajima, T.; Kubota, N.; Tsutsumi, T.; Oguri, A.; Imuta, H.; Jo, T.; Oonuma, H.; Soma, M.; Meguro, K.; Takano, H.; Nagase, T.; Nagata, T. Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells. Br. J. Pharmacol., 2009, 156(3), 420-431.
120. Brown, M.D.; Hart, C.A.; Gazi, E.; Bagley, S.; Clarke, N.W. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br. J. Cancer, 2006, 94(6), 842-853.
121. Notarnicola, M.; Messa, C.; Refolo, M.G.; Tutino, V.; Miccolis, A.; Caruso, M.G. Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells. Lipids Health Dis., 2010, 9:135.
122. Lee, C.Y.; Sit, W.H.; Fan, S.T.; Man, K.; Jor, I.W.; Wong, L.L.; Wan, M.L.; Tan-Un, K.C.; Wan, J.M. The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carcinoma proliferation. Int. J. Oncol. 2010, 36(4), 991-9988
123. Mita, R.; Beaulieu, M.J.; Field, C.; Godbout, R. Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration. J. Biol. Chem., 2010, 285(47), 37005-37015.
124. Fekete, K.; Marosvölgyi, T.; Jakobik, V.; Decsi, T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am. J. Clin. Nutr., 2009, 89(6), 2070S-2084S.
125. Calviello, G.; Palozza, P.; Franceschelli, P.; Bartoli, G.M. Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids, 1997, 32(10), 1075-1083. (Pubitemid 27459416)
126. Brenna, J.T.; Salem, N.Jr.; Sinclair, A.J.; Cunnane, S.C.; International Society for the Study of Fatty Acids and Lipids, ISSFAL. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids, 2009, 80(2-3), 85-91.